Technical Analysis for PRPH - ProPhase Labs, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
D | 4.71 | -4.85% | -0.24 |
Earnings due: May 9
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Wide Bands | Range Expansion | 0.00% | |
Down 3 Days in a Row | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
200 DMA Resistance | Bearish | -4.85% | |
Calm After Storm | Range Contraction | -4.85% | |
Wide Bands | Range Expansion | -4.85% | |
Oversold Stochastic | Weakness | -4.85% | |
200 DMA Resistance | Bearish | -6.92% | |
Stochastic Buy Signal | Bullish | -6.92% | |
Calm After Storm | Range Contraction | -6.92% |
Alert | Time |
---|---|
60 Minute Opening Range Breakdown | about 16 hours ago |
2x Volume Pace | about 21 hours ago |
Down 5% | about 21 hours ago |
Lower Bollinger Band Support | about 21 hours ago |
1.5x Volume Pace | about 21 hours ago |
Get this analysis on your stocks daily!
- Earnings date: 05/09/2024
ProPhase Labs, Inc. Description
ProPhase Labs, Inc. engages in the manufacture, marketing, and distribution of homeopathic and health products to the general public. It is also involved in the research and development of over-the-counter (OTC) drugs, natural base health products with supplements, personal care, and cosmeceutical products. The company offers Cold-EEZE, a zinc gluconate glycine lozenge to reduce the duration and severity of the common cold symptoms. It also markets and distributes two non-lozenge forms of its proprietary zinc gluconate formulation, Cold-EEZE daytime/nighttime QuickMelts and Cold-EEZE oral spray; and Kids-EEZE products for children suffering from upper respiratory infections, allergy, and/or chest congestion, as well as organic cough drops and a Vitamin C supplements. It also provides private label lozenge products for retail customers; and performs contract manufacturing services of cough drop and other OTC cold remedy products for third parties. ProPhase Labs, Inc. sells its products through food, multi-outlet pharmacy and chain drug stores, wholesalers, and mass merchandisers in the United States. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Doylestown, Pennsylvania.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Vitamins Health Products Dietary Supplement Allergy Zinc Contract Manufacturing Contract Manufacturing Services Cough Over The Counter Drug Respiratory Infection Upper Respiratory Infection
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 9.9 |
52 Week Low | 4.05 |
Average Volume | 60,924 |
200-Day Moving Average | 5.17 |
50-Day Moving Average | 5.50 |
20-Day Moving Average | 6.04 |
10-Day Moving Average | 5.53 |
Average True Range | 0.50 |
RSI (14) | 37.89 |
ADX | 20.05 |
+DI | 19.18 |
-DI | 26.80 |
Chandelier Exit (Long, 3 ATRs) | 5.99 |
Chandelier Exit (Short, 3 ATRs) | 6.10 |
Upper Bollinger Bands | 7.59 |
Lower Bollinger Band | 4.49 |
Percent B (%b) | 0.07 |
BandWidth | 51.34 |
MACD Line | -0.22 |
MACD Signal Line | 0.01 |
MACD Histogram | -0.2247 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 5.23 | ||||
Resistance 3 (R3) | 5.26 | 5.10 | 5.15 | ||
Resistance 2 (R2) | 5.10 | 4.97 | 5.09 | 5.12 | |
Resistance 1 (R1) | 4.91 | 4.89 | 4.83 | 4.88 | 5.09 |
Pivot Point | 4.75 | 4.75 | 4.72 | 4.74 | 4.75 |
Support 1 (S1) | 4.56 | 4.62 | 4.48 | 4.54 | 4.33 |
Support 2 (S2) | 4.40 | 4.54 | 4.39 | 4.30 | |
Support 3 (S3) | 4.21 | 4.40 | 4.27 | ||
Support 4 (S4) | 4.19 |